Jeena Sikho Lifecare Limited Q1 FY26 results deck summary

Results deck of 15 Aug 2025, summarised by AI from the filing.

Original filing on BSE

Jeena Sikho Lifecare Limited Q1 FY27 results

As filed: Revenue ₹224 cr (+29% year on year), EBITDA ₹92.1 cr (+15% year on year), PAT ₹65.9 cr (+29% year on year), EBITDA margin 41.0% (−495 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹216 cr (−15% year on year), EBITDA ₹78.0 cr (+18% year on year), PAT ₹45.4 cr (+3% year on year), EBITDA margin 36.2% (+1,000 bps). Score 41 of 100, In line with trend. EBITDA margin rose 1000 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 32% from last quarter. Share price after the results: −4.6% in 30 days (Nifty 500: +1.5%).
• Q3 FY26: Revenue ₹222 cr, EBITDA ₹101 cr, PAT ₹66.7 cr, EBITDA margin 45.5%. Not scored. No result for the same quarter last year. Share price after the results: −14.4% in 30 days (Nifty 500: −5.9%).
• Q2 FY26: Revenue ₹190 cr (−11% year on year), EBITDA ₹92.1 cr (+56% year on year), PAT ₹58.8 cr (+25% year on year), EBITDA margin 48.5% (+1,000 bps). Score 60 of 100, In line with trend. EBITDA margin rose 1000 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −12.8% in 29 days (Nifty 500: +1.4%).
• Q1 FY26: Revenue ₹174 cr, EBITDA ₹80.0 cr, PAT ₹51.0 cr, EBITDA margin 46.0%. Not scored. No result for the same quarter last year. Share price after the results: +40.7% in 29 days (Nifty 500: +2.2%).
• Q4 FY25: Revenue ₹255 cr, EBITDA ₹66.0 cr, PAT ₹44.0 cr, EBITDA margin 25.9%. Not scored. No result for the same quarter last year.
• Q2 FY25: Revenue ₹214 cr (+173% year on year), EBITDA ₹59.0 cr (+162% year on year), PAT ₹47.0 cr (+194% year on year), EBITDA margin 27.6% (−109 bps). Score 89 of 100, Above trend. EBITDA margin fell 109 bps year on year. Year-ago figures are half of the company's half-year result (it reported half-yearly then). Not enough history for a trend yet: scored on growth alone.
• H1 FY24: Revenue ₹157 cr, EBITDA ₹45.0 cr, PAT ₹32.0 cr, EBITDA margin 28.7%. Not scored. No result for the same half-year last year.

Past price moves after results do not indicate future moves. Not a recommendation.

Jeena Sikho Lifecare Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (10 Aug 2026), Results deck (9 Aug 2026)
• Q4 FY26: Earnings call (2 Jun 2026), Results deck (31 May 2026), Results deck (1 Jun 2026)
• Q3 FY26: Earnings call (9 Feb 2026), Results deck (8 Feb 2026)
• Q2 FY26: Earnings call (7 Nov 2025), Results deck (6 Nov 2025)
• Q1 FY26: Earnings call (18 Aug 2025), Results deck (15 Aug 2025), Results deck (16 Aug 2025)